Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Hebert

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Current Hypertension Reports|September 12, 2000
Target blood pressure for antihypertensive therapy in patients with proteinuric renal diseaseL A Hebert
Journal of the American Society of Nephrology : JASN|February 1, 1995
Therapy of membranous nephropathy: what to do after the after (meta) analysesL A Hebert
Journal of the American Society of Nephrology : JASN|November 1, 1994
Jacob Lemann, Jr., MD--the Milwaukee yearsL A Hebert
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1988
Disposition of IgA-containing circulating immune complexesL A Hebert
Occupational Health & Safety (Waco, Tex.)|April 1, 1993
Analytical focus reduces anxiety over CTD claimsL A Hebert
Kidney International|January 5, 2000
Renoprotective therapy: how good can it get?L A Hebert
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Apheresis is of value in SLEL A Hebert
Occupational Health & Safety (Waco, Tex.)|October 1, 1992
Body at workL A Hebert
Physical Therapy|March 1, 1979
Metacarpophalangeal joint replacement. Case report of 20-year follow-upL A Hebert
Transactions of the Association of Life Insurance Medical Directors of America|January 1, 1989
On the natural tendency for renal disease to progress: can interventions slow this progression?L A Hebert
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Current Hypertension Reports|September 12, 2000
Target blood pressure for antihypertensive therapy in patients with proteinuric renal diseaseL A Hebert
Journal of the American Society of Nephrology : JASN|February 1, 1995
Therapy of membranous nephropathy: what to do after the after (meta) analysesL A Hebert
Journal of the American Society of Nephrology : JASN|November 1, 1994
Jacob Lemann, Jr., MD--the Milwaukee yearsL A Hebert
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1988
Disposition of IgA-containing circulating immune complexesL A Hebert
Occupational Health & Safety (Waco, Tex.)|April 1, 1993
Analytical focus reduces anxiety over CTD claimsL A Hebert
Kidney International|January 5, 2000
Renoprotective therapy: how good can it get?L A Hebert
Transactions - American Society for Artificial Internal Organs|January 1, 1984
Apheresis is of value in SLEL A Hebert
Occupational Health & Safety (Waco, Tex.)|October 1, 1992
Body at workL A Hebert
Physical Therapy|March 1, 1979
Metacarpophalangeal joint replacement. Case report of 20-year follow-upL A Hebert
Transactions of the Association of Life Insurance Medical Directors of America|January 1, 1989
On the natural tendency for renal disease to progress: can interventions slow this progression?L A Hebert
Pageof 10